Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

2.

Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.

3.

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

4.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

5.

Advancing Health in Africa


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot